Rigel Pharmaceuticals
RIGL
RIGL
159 hedge funds and large institutions have $614M invested in Rigel Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 47
0.16% less ownership
Funds ownership: 8.48% → 8.32% (-0.16%)
5% less call options, than puts
Call options by funds: $3.43M | Put options by funds: $3.61M
Holders
159
Holding in Top 10
2
Calls
$3.43M
Puts
$3.61M
Top Buyers
| 1 | +$9.64M | |
| 2 | +$6.51M | |
| 3 | +$4.13M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.77M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.63M |
Top Sellers
| 1 | -$14M | |
| 2 | -$8.46M | |
| 3 | -$7.92M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$5.05M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.97M |